You have 9 free searches left this month | for more free features.

abemaciclib

Showing 1 - 25 of 137

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer Trial (Abemaciclib, Letrozole)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Nov 14, 2023

Meningioma Trial in Phoenix (Abemaciclib, Placebo)

Not yet recruiting
  • Meningioma
  • Abemaciclib
  • Placebo
  • Phoenix, Arizona
    St. Joseph's Hospital and Medical Center
Jul 4, 2023

Luminal Metastatic breAst caNcer in Real-life Clinical pracTice

Completed
  • HR+/HER2- Breast Cancer
  • +2 more
  • Abemaciclib
  • Moscow, Russian Federation
    Russian Society of Clinical Oncology
Mar 29, 2023

Low Grade Serous Ovarian Carcinoma, Adult Type Granulosa Cell Tumor Trial in Gent, Leuven, Liège (Abemaciclib, Letrozole)

Not yet recruiting
  • Low Grade Serous Ovarian Carcinoma
  • Adult Type Granulosa Cell Tumor
  • Gent, Oost-Vlaanderen, Belgium
  • +2 more
May 12, 2023

Retroperitoneal Sarcoma Trial in Seattle (drug, procedure, radiation)

Not yet recruiting
  • Retroperitoneal Sarcoma
  • Abemaciclib
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 5, 2023

Kaposi Sarcoma Trial run by the NCI (Abemaciclib)

Recruiting
  • Kaposi Sarcoma
  • Abemaciclib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Neurofibromatosis 1 Trial run by the National Cancer Institute (NCI) (Abemaciclib)

Recruiting
  • Neurofibromatosis 1
  • Abemaciclib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Hepatocellular Carcinoma Trial in Philadelphia (Abemaciclib, Nivolumab)

Terminated
  • Hepatocellular Carcinoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Nov 17, 2022

Solid Tumor, Advanced Breast Cancer Trial in Milwaukee (Abemaciclib, Hydroxychloroquine 200 mg, Faslodex)

Withdrawn
  • Solid Tumor
  • Advanced Breast Cancer
  • Abemaciclib
  • +6 more
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
Dec 21, 2022

Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Abemaciclib
  • +5 more
  • Boston, Massachusetts
  • +7 more
Aug 14, 2023

Cancer Trial in Boston (Abemaciclib)

Recruiting
  • Cancer
  • Abemaciclib
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 9, 2023

Malignant Tumors of Female Genital Organs Trial in Houston (Fulvestrant, Abemaciclib)

Active, not recruiting
  • Malignant Neoplasms of Female Genital Organs
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 5, 2022

Breast Cancer Trial in Boston (Abemaciclib)

Terminated
  • Breast Cancer
  • Abemaciclib
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Oct 3, 2022

Cancer, Cancer Metastatic, BRAF V600E Trial in Indianapolis (Abemaciclib, LY3214996)

Recruiting
  • Cancer
  • +6 more
  • Indianapolis, Indiana
    Indiana University Hospital / IU Simon Cancer Center
Jan 12, 2023

Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Boston (Abemaciclib, Atezolizumab)

Recruiting
  • Prostate Cancer
  • Metastatic Castration-resistant Prostate Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Sep 26, 2022

Prostatic Tumors Trial in Germany, Spain, United States (Abemaciclib, Darolutamide, LHRH agonist/antagonist)

Not yet recruiting
  • Prostatic Neoplasms
  • Abemaciclib
  • +2 more
  • Mineola, New York
  • +14 more
Aug 23, 2023

Sarcoma, Dedifferentiated Liposarcoma Trial in New York (Abemaciclib)

Active, not recruiting
  • Sarcoma
  • Dedifferentiated Liposarcoma
  • Abemaciclib
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 17, 2022

Metastatic Prostate Cancer, Non-metastatic Prostate Cancer, Prostate Cancer Trial in Boston (Darolutamide, Abemaciclib, GNRH-A

Not yet recruiting
  • Metastatic Prostate Cancer
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Nov 14, 2022

Thyroid Cancer, Anaplastic Thyroid Cancer, Undifferentiated Thyroid Cancer Trial in Stanford (Abemaciclib)

Active, not recruiting
  • Thyroid Cancer
  • +2 more
  • Abemaciclib
  • Stanford, California
    Stanford University
Nov 8, 2022

Breast Tumors, Brain Tumors, Tumors by Site Trial (Abemaciclib, Elacestrant)

Recruiting
  • Breast Neoplasms
  • +7 more
  • Canton, Ohio
    Gabrail Cancer Center
Jan 24, 2023

Glioblastoma Trial in United States (Abemaciclib, Surgery)

Active, not recruiting
  • Glioblastoma
  • Abemaciclib
  • Surgery
  • Los Angeles, California
  • +6 more
Dec 28, 2022

Brain Metastases, HR+ Metastatic Breast Cancer Trial in Tampa (Stereotactic Radiosurgery (SRS), Abemaciclib, Endocrine therapy)

Recruiting
  • Brain Metastases
  • HR+ Metastatic Breast Cancer
  • Stereotactic Radiosurgery (SRS)
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Nov 1, 2022

Myelofibrosis Due to and Following Polycythemia Vera Trial in United States (Ruxolitinib, Abemaciclib)

Recruiting
  • Myelofibrosis Due to and Following Polycythemia Vera
  • Basking Ridge, New Jersey
  • +6 more
Jan 26, 2023

Clear Cell Renal Cell Carcinoma Trial in Boston (Abemaciclib, MK-6482)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Boston, Massachusetts
  • +1 more
Dec 14, 2022